Citadel Advisors’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,829
Closed -$32K 15593
2022
Q3
$32K Sell
5,829
-2,925
-33% -$55.8K ﹤0.01% 11879
2022
Q2
$493K Buy
8,754
+5,017
+134% +$274K ﹤0.01% 8688
2022
Q1
$221K Buy
3,737
+14
+0.4% +$713 ﹤0.01% 11296
2021
Q4
$257K Sell
3,723
-1,826
-33% -$141K ﹤0.01% 11281
2021
Q3
$398K Buy
5,549
+3,240
+140% +$253K ﹤0.01% 10424
2021
Q2
$193K Buy
2,309
+666
+41% +$50.5K ﹤0.01% 12198
2021
Q1
$115K Buy
+1,643
New +$128K ﹤0.01% 12346
2020
Q2
Sell
-306
Closed -$14K 10652
2020
Q1
$14K Buy
+306
New +$14.4K ﹤0.01% 9373
2018
Q2
Sell
-449
Closed -$36K 9388
2018
Q1
$36K Buy
449
+126
+39% +$25.4K ﹤0.01% 8008
2017
Q4
$80K Buy
+323
New +$75.1K ﹤0.01% 7501

Other funds holding NTBL

Citadel Advisors's NTBL Position: Q1 2023 in Review

Citadel Advisors sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q1 2023, closing a stake of 3,666 shares — an estimated $15.4K sold.

Citadel Advisors first reported a position in NTBL in Q1 2017 and held it in 12 quarters. The position peaked at $303K in Q2 2021. 18 funds tracked by Wall St. Rank hold NTBL as of Q1 2023.

  • Citadel Advisors reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 3,666 Notable Labs, Ltd. Ordinary Shares shares in Q1 2023, an estimated $15.4K.
  • Citadel Advisors first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2017 and held it in 12 quarters.
  • Citadel Advisors's Notable Labs, Ltd. Ordinary Shares position peaked at $303K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.